ALXN : Analysis & Opinions

  1. AMCPX: American Funds AMCAP Portfolio Top 5 Holdings Analysis ...

    May 7, 2016
    Discover the American Funds AMCAP Fund, a large-cap growth fund that seeks stocks with attractive valuations and long-term ...
  2. PRHSX: T Rowe Price Health Sciences Fund Performance Case Study

    May 4, 2016
    Learn more about the T. Rowe Price Health Sciences Fund, including the historical performance and financial trends by quarter ...
  3. PRHSX: T. Rowe Health Sciences Fund Top 5 Holdings Analysis

    April 2, 2016
    Learn about the T. Rowe Price Health Sciences mutual fund, its portfolio make-up, and complete analysis of the fund's top ...
  4. 5 Punished Stocks: Are They Bargains? (ENDP,VRTX)

    March 31, 2016
    These five stocks have been slammed recently. Does this mean they are now bargains?
  5. PRHSX: Portfolio Trends in 2016

    March 23, 2016
    Discover how the T. Rowe Price Health Sciences Fund is positioned in 2016, and learn what trends in the portfolio may help ...
  6. TROW: Overview of T. Rowe Price Health Sciences Fund

    March 20, 2016
    Learn about the health care sector's performance in 2016 and how T. Rowe Price's funds have fared. Discover an overview of ...
  7. TRBCX: Overview of T. Rowe Price Blue Chip Growth Fund

    March 19, 2016
    Learn about the T. Rowe Price Blue Chip Growth Fund and its investment philosophy, portfolio composition, management, performance ...
  8. Why These Could Be 2015's 10-Best Pharma Stocks (ABBV, ALXN)

    March 17, 2015
    The pharmaceutical stocks covered here have significant potential going forward. Here's why.
  9. The Biggest Biotech Companies

    January 15, 2015
    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...
  10. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    November 12, 2013
    Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
  11. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    September 14, 2013
    Declining short interest in Alexion Pharmaceuticals (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical ...
  12. Roche Delivering Leverage, But Still Needs Diversification

    July 29, 2013
    If Roche can balance out its sales mix, the long-term value could be quite compelling at present prices.
  13. Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, ...

    June 26, 2013
    Among biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG) and saw the most significant rise in short interest ...
  14. Alnylam Basking In Orphan Drug Attention

    May 28, 2013
    Alnylam has already seen a big run, but clinical success could bring even more gains.
  15. Alexion Pharmaceuticals and Other Nasdaq Stocks Making Big Moves ...

    January 2, 2013
    After this morning's trading, the market is looking good. The Nasdaq is trading up 2.3%; the S&P 500 is up 1.8%; and ...
  16. Alexion Pharmaceuticals and More Big Movers in Healthcare on ...

    December 7, 2012
    So far today, the Nasdaq is down 0.7%, the S&P 500 is unchanged and the Dow is trading up 0.3%. The healthcare sector ...
  17. Amgen and Other Healthcare Stocks Making Big Moves on October ...

    October 19, 2012
    The market is having a bad day so far: the Nasdaq has slipped 1.6%; the S&P 500 is trading down 1%; and the Dow is down ...
  18. Healthcare Stocks, Including Eli Lilly, Making Big Moves on August ...

    August 24, 2012
    The Nasdaq has increased 0.6%, the S&P 500 has risen 0.5% and the Dow has moved up 0.6% on a good day for the market ...
  19. Biggest Healthcare Sector Movers, Including ALXN

    August 3, 2012
    On a good day for the market, the Nasdaq has climbed 2.2%, the S&P 500 has increased 2% and the Dow is up 1.8%. The healthcare ...
  20. 5 Medical Stocks with Healthy Charts

    February 14, 2012
    Within the health-care sector are some companies with a good mix of technical and fundamental promise. However, some are ...
  21. Big Bets on High-Flying Pharma Stock

    February 9, 2012
    Following bullish earnings, Karee Venema of Schaeffer’s Research writes that call buyers are piling in to one biopharmaceutical ...
  22. Healthcare Stocks On The Move

    December 13, 2011
    These four healthcare stocks are showing above-average performance.
  23. Should Biotech Investors Go Where Institutions Won't?

    July 7, 2011
    A lack of institutional ownership should be a warning sign for biotech investors.
  24. Drug Manufacturers Showing Strength

    November 16, 2010
    Drug Manufacturers Showing Strength
Trading Center